What's Happening?
Jessica Ravelo, a clinical research executive and registered nurse, has transformed Altus Clinical Research into a leading independent clinical research organization in South Florida. Starting with a $100,000 investment, Ravelo has grown the company into a multimillion-dollar
enterprise, generating approximately $3 million in annual revenue. Altus is known for its operational excellence and regulatory integrity, supporting Phase I through IV trials across various therapeutic areas. The company partners with pharmaceutical and biotechnology sponsors to bring innovative therapies to market. Ravelo's leadership emphasizes a people-first philosophy, fostering a culture of excellence and community impact through local health initiatives and patient education.
Why It's Important?
The growth of Altus Clinical Research under Jessica Ravelo's leadership highlights the potential for independent clinical research organizations to compete with larger networks. By maintaining rigorous quality systems and a strong regulatory track record, Altus provides a reliable option for sponsors seeking to conduct high-stakes trials. This development is significant for the U.S. healthcare industry as it underscores the importance of operational excellence and ethical standards in clinical research. The company's success also demonstrates the impact of leadership that prioritizes both business growth and community engagement, potentially setting a new standard for the industry.
